TCTugba Uyar Cankay

Tugba Uyar Cankay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tugba Uyar Cankay has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Greater and Lesser Occipital Nerve Blocks for Frequent and Severe Headaches in Children and Adolescents: A Protocolized Repetitive Intervention Study

    by Tuğba Uyar Cankay, Ömer Lütfi Gündoğdu, Bahar Taşdelen, Derya Uluduz, Aynur Özge

    Introduction Headache management in children and adolescents remains challenging, particularly in patients with high headache-related disability, medication overuse, and comorbid conditions, for whom evidence-based preventive treatment options are limited and often ineffective. This study aimed to evaluate the clinical outcomes and safety of a protocolized, repetitive bilateral greater and lesser occipital nerve block (GONB/LONB) strategy in pediatric patients with frequent and severe headaches. Methods This retrospective study included adolescents aged 11–18 years who underwent bilateral GONB and LONB for headache between 2018 and 2025. At each treatment session, 1 mL of 2% lidocaine was administered at each of four injection sites (bilateral GON and LON), corresponding to a total volume of 4 mL (80 mg) per session. Blocks were administered weekly for 4 weeks, followed by additional applications at 1 and 3 months. Headache severity and disability were evaluated using the visual analog scale (VAS) and the Pediatric Migraine Disability Assessment (PedMIDAS) before and after completion of the block protocol. Results Forty-five patients (91.1% female) received a total of 258 bilateral GONB/LONB procedures. The mean number of headache days per month was 20.8 ± 7.9, and the mean headache duration was 11.6 ± 10.7 months. Significant reductions were observed in both VAS and PedMIDAS disability grades following treatment (p < 0.001). At the patient level, 41 of 45 patients (91.1%) met the predefined criteria for clinical response. No serious adverse events occurred. Conclusions Protocolized repetitive bilateral GONB/LONB was well tolerated and was associated with reductions in headache severity and headache-related disability in this predominantly adolescent cohort. However, the uncontrolled retrospective design precludes attribution of these improvements specifically to the intervention. Prospective sham-controlled studies are needed to establish treatment-specific efficacy.

  • Essential tremor: Family-based sequencing suggests involvement of neuronal and metabolic pathways

    by Agharza Aghayev, Melda Erdoğdu, Duygu Aydemir, Gulendam Bagirova, Ayca Dilruba Aslanger, Tugba Uyar Cankay, Nihan Hande Akcakaya, Zehra Oya Uyguner


  • Open Access

    Impulsiveness levels among patients with medication-overuse headache accompanying chronic migraine or tension-type headache

    by Ruken Simsekoglu, Nestug Keskin, Tugba Cankay, Sumeyye Cakmak, Temel Tombul

    Impulsiveness in primary headaches is not well understood.To analyze impulsiveness in patients with medication-overuse headache (MOH) and either chronic migraines or chronic tension-type headaches (TTHs).This cross-sectional study included 119 participants (96 female) divided into 3 groups: the migraine with MOH (M-O, n = 44, age = 36.6 ± 11.1), the tension-type headache with MOH group (TTH-O, n = 38, age = 42.6 ± 11.8), and the healthy control group (HC, n = 37, age = 36.9 ± 13.1). The Barratt Impulsiveness Scale-11 Short Form (BIS-11 SF), Beck's Depression Inventory (BDI), Beck's Anxiety Inventory (BAI), and Pittsburgh Sleep Quality Index (PSQI) were used to assess impulsiveness, depression, anxiety, and sleep quality, respectively.Impulsiveness levels were significantly higher in the M-O (p < 0.01) and TTH-O (p < 0.01) groups compared with the HC. However, no significant difference in impulsiveness was found between the M-O and TTH-O (p > 0.05). The PSQI scores were significantly higher in the M-O and TTH-O compared with the HC (p < 0.01). Additionally, anxiety scores were notably higher in the M-O compared with both the TTH-O and HC (p < 0.01).The present study, which compared the M-O and TTH-O groups with HC in terms of impulsiveness, with no significant differences in parameters such as age, gender, schooling, frequency of headache attacks, and disease onset duration, concluded that both patient groups exhibited higher impulsiveness compared with the controls. Furthermore, the lack of difference in impulsiveness between MO and chronic TTH-O patients with a common denominator of MOH suggests that it may be associated with MOH, which is a shared subset of two distinct headache disorders.


  • Associations between diet quality, DASH and Mediterranean dietary patterns and migraine characteristics

    by Hande Bakırhan, Hilal Yıldıran, Tugba Uyar Cankay

    This study was conducted to describe the dietary patterns and diet quality and to examine the correlation between diet quality, dietary patterns (Mediterranean or DASH) and migraine attributes.Indi...


  • Sağlıkta Yapay Zeka ve Uygulamaları

    by Sevda Ünallı Özmen, Esra Meltem Koç, Hilal Aksoy, Mikail Özdemir, Aysun Albayrak, Uğur Coruh, Osman Pirhan, Tolga Çakmak, Eyüp Özkan, Mevlüt Demir, et al.

    Saygıdeğer okuyucular,Her şeyden önce size teşekkür etmek istiyorum, bilgi çağında, bilgiden yoksun, bilgiden uzak işini yapadurmak yerine, sağlık alanındaki inovasyon, teknoloji ve yapay zeka kulvarlarındaki merakınız ve hekimseniz hastanıza en doğru tanıyı koyup, en doğru tedaviyi vermek gayesi yada alan uzmanı iseniz de bu alanlarda gelişime inanarak okumayı seçtiğiniz, konfor alanınızı bozmayı kabul ettiğiniz için.Bu kitapta sağlığımızın geleceğinin büyük bir kısmını oluşturacak olan, sağlığın yapay zekasını size sunduk. Yapay zekanın sağlık alanındaki gelişmelerini, karar destek sistemlerini, büyük veriyi ve gelecek perspektifini en güncel bilgiler ışığında bu kitapta bulacaksınız.


  • Open Access

    Negative effects of accompanying psychiatric disturbances on functionality among adolescents with chronic migraine

    by Tugba Uyar Cankay, Mert Besenek

    Background Chronic migraine is a condition with gradually increasing prevalence among adolescents which causes severe headaches resulting in functionality loss. Factors contributing to migraine becoming chronic and negatively affecting quality of life in adolescence are still unclear. Parallel with these, we aimed to examine the effect of psychiatric symptoms on headache severity and functionality loss among adolescents with chronic migraine. Methods We evaluated features of 50 adolescents who were diagnosed with chronic migraine according to International Classification of Headache Disorders-3 for the first time in their lives by an experienced neurologist. Sociodemographic and clinical data were collected and Pediatric Migraine Disability Assessment Score, Visual Analogue Score and DSM-5 Level 1 Cross-Cutting Symptom Measure Scores (CCSM-5) were evaluated. Semi-structured psychiatric interviews were done to those who scored higher than cut-off scores on CCSM-5. Healthy control group was constituted of cases which had similar age and sex distribution to case group. Results Majority of the case group was female (%78). There was a positive correlation between headache severity and computerized tomography history in emergency department. All of the psychiatric symptom scores were significantly higher in case group except for psychotic symptoms; but attention problems and manic symptoms clusters did not have significant difference according to the thresholds of CCSM-5. Receiving a psychiatric diagnosis did not affect frequency, severity or duration of headaches. There were also no relationship between depression/anxiety diagnosis and severity of headache/functionality loss. Conclusion Findings suggest that; more rational treatment methods with lesser functionality loss should be developed by adopting multidisciplinary and prospective approach via psychiatric screening for adolescents with chronic migraine.